Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva to acquire Allergan for $40B
Do Analysts Expect Teva Pharmaceutical Industries Ltd (TEVA) Stock to Rise After It Has Gained 10.21% in a Month?
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Teva® Announces the Arrival of its Latest Collection for Fall 2022
Teva Pharmaceutical Industries and opioid settlement: What to know
Teva Pharmaceutical Industries names a new CEO
TEVA Plunges on Q1 Results - TipRanks.com
Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults
teva News and latest stories | The Jerusalem Post
Why Teva Pharmaceutical Stock Is Jumping Today | The Motley Fool
Watch CNBC's full interview with Teva CEO Kåre Schultz
Teva Pharmaceutical Industries Ltd. - Home | Facebook
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva to Launch New Growth Strategy at Investor Day
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals Ireland today launches the first national respiratory inhaler recycling pilot
Teva Pharmaceutical Industries | Pharma 50
Teva CEO Richard Francis, after 120 days at the helm, preps grand strategic reveal